Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
The Lancet Haematology (2020) Vol. 7, Iss. 10, pp. e737-e745
Open Access | Times Cited: 522

Showing 1-25 of 522 citing articles:

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Abi Vijenthira, Inna Y. Gong, Thomas A. Fox, et al.
Blood (2020) Vol. 136, Iss. 25, pp. 2881-2892
Open Access | Times Cited: 584
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. 765-778
Open Access | Times Cited: 578
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Akshay Sharma, Neel S. Bhatt, Andrew St. Martin, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 3, pp. e185-e193
Open Access | Times Cited: 335
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 262
COVID-19 and Cancer: Current Challenges and Perspectives
Ziad Bakouny, Jessica E. Hawley, Toni K. Choueiri, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 629-646
Open Access | Times Cited: 257
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2021) Vol. 78, Iss. 7, pp. e170-e207
Open Access | Times Cited: 175
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
Fulvia Pimpinelli, Francesco Marchesi, Giulia Piaggio, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 166
BNT162b2 COVID‐19 vaccine is significantly less effective in patients with hematologic malignancies
Katrin Herzog Tzarfati, Odit Gutwein, Arie Apel, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1195-1203
Open Access | Times Cited: 155
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Lindsey E. Roeker, David A. Knorr, Meghan C. Thompson, et al.
Leukemia (2021) Vol. 35, Iss. 9, pp. 2703-2705
Open Access | Times Cited: 147
Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
Rémy Duléry, Sylvain Lamure, Marc Delord, et al.
American Journal of Hematology (2021) Vol. 96, Iss. 8, pp. 934-944
Open Access | Times Cited: 134
COVID-19 in patients with hematologic malignancy
Petra Langerbeins, Michael Hallek
Blood (2022) Vol. 140, Iss. 3, pp. 236-252
Open Access | Times Cited: 108
Hematological Abnormalities in COVID-19: A Narrative Review
Asma Rahman, Roshan Niloofa, Umesh Jayarajah, et al.
American Journal of Tropical Medicine and Hygiene (2021) Vol. 104, Iss. 4, pp. 1188-1201
Open Access | Times Cited: 106
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
Simone Cesaro, Per Ljungman, Małgorzata Mikulska, et al.
Leukemia (2022) Vol. 36, Iss. 6, pp. 1467-1480
Open Access | Times Cited: 105
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 74
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2022) Vol. 140, Iss. 26, pp. 2773-2787
Open Access | Times Cited: 69
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 15
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
William A. Wood, Donna Neuberg, John Colton Thompson, et al.
Blood Advances (2020) Vol. 4, Iss. 23, pp. 5966-5975
Open Access | Times Cited: 134
Impact of COVID-19 in solid organ transplant recipients
Lara Danziger‐Isakov, Emily A. Blumberg, Oriol Manuel, et al.
American Journal of Transplantation (2020) Vol. 21, Iss. 3, pp. 925-937
Open Access | Times Cited: 124
The immuno-oncological challenge of COVID-19
Lisa Derosa, Cléa Melenotte, Frank Griscelli, et al.
Nature Cancer (2020) Vol. 1, Iss. 10, pp. 946-964
Open Access | Times Cited: 116
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S. Pathania, Philip Prathipati, Abdul Bakrudeen Ali Ahmed, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 731-753
Open Access | Times Cited: 113
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
Paola Ghione, Juan J. Gu, Kristopher Attwood, et al.
Blood (2021) Vol. 138, Iss. 9, pp. 811-814
Open Access | Times Cited: 94
T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
Vincenzo Marasco, Cristiana Carniti, Anna Guidetti, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 548-558
Open Access | Times Cited: 90
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, et al.
Leukemia (2021) Vol. 35, Iss. 12, pp. 3444-3454
Open Access | Times Cited: 85
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, et al.
Blood (2021) Vol. 139, Iss. 10, pp. 1588-1592
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top